Showing results (1-10 of 259) with videos related to

Sort By:
Pageof 26
International Journal of Hematology|November 21, 2024
Current treatment approach and future perspectives in B cell lymphomaNobuhiko Yamauchi, Dai Maruyama
European Journal of Haematology|January 3, 2024
Current development of chimeric antigen receptor T-cell therapy for diffuse large B-cell lymphoma and high-grade B-cell lymphomaNobuhiko Yamauchi, Dai Maruyama
Japanese Journal of Clinical Oncology|October 9, 2025
Recent advances and future perspectives in frontline treatment of peripheral T-cell lymphomaYuko Shirouchi, Nobuhiko Yamauchi, Dai Maruyama
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 3, 2026
[Recent advances and future perspectives in the treatment of classical Hodgkin lymphoma]Nobuhiko Yamauchi
The Journal of Reproduction and Development|January 7, 2026
Development of a three-dimensional culture model of endometrium to study embryo-uterine interactionsNobuhiko Yamauchi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 1, 2025
[Treatment strategy for classical Hodgkin lymphoma and future perspectives]Nobuhiko Yamauchi
Journal of Clinical and Experimental Hematopathology : JCEH|March 27, 2024
Complex karyotype determined using conventional cytogenetic analysis is a poor prognostic factor in patients with multiple myelomaHideki Uryu, Yuko Mishima, Yuko Ishihara, et al.
British Journal of Haematology|July 28, 2016
Clinicopathological features of histological transformation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue to diffuse large B-cell lymphoma: an analysis of 467 patientsAkiko Miyagi Maeshima, Hirokazu Taniguchi, Kosuke Toyoda, et al.
The Journal of International Medical Research|April 19, 2017
Azacitidine-induced acute lung injury in a patient with therapy-related myelodysplastic syndromeShinichi Makita, Wataru Munakata, Daisuke Watabe, et al.
Cancer Immunology, Immunotherapy : CII|August 15, 2016
Prognostic significance of HLA class I and II expression in patients with diffuse large B cell lymphoma treated with standard chemoimmunotherapyKohei Tada, Akiko Miyagi Maeshima, Nobuyoshi Hiraoka, et al.
Pageof 26